Hematology/Oncology

Division chief Roberto Pili, MD.

Members of our division conduct cutting-edge research to further knowledge and advance treatment for cancer and blood disorders.

The mission of the new Division of Hematology/Oncology at UB-Great Lakes Cancer Care is to reduce the cancer burden in Western New York by providing the highest quality cancer care and innovative research aimed to reduce incidence and mortality, educating the new generation of cancer researchers and oncologists and conducting cancer prevention programs specific for WNY community. The overall goal is to programmatically integrate clinical care, translational research and professional training, thereby strengthening the delivery of care to the community and enhancing clinical research by creating a new Center of Excellence for cancer patient care in Western New York.

The Division of Hematology and Oncology was established in May 2020 when Dr. Pili was named the new Chief. Previously, the clinical members of the Department of Medicine at Roswell Park Cancer Institute were the faculty members of the Division. The division consists of 11 clinical faculty members (two will join in the summer of 2025) and three non-clinical faculty members. Since its inception, the new division’s goal has been to integrate Great Lakes Cancer Care physicians into an academic program to provide a multi-disciplinary expertise in several areas of solid tumors (i.e. breast, thoracic, gastrointestinal, genitourinary malignancies), heme malignancies (i.e. lymphomas, myelodysplastic syndrome etc.) and benign hematology. Dr. Pili has been responsible for the academic growth of the faculty members of the division. The faculty members are involved in clinical care, clinical research and teaching, and participate to the activities proposed/required by the Department of Medicine. The establishment of a clinical trial portfolio across the different diseases with emphasis on investigator-initiated clinical trials has been a major focus for the division.

Overall, the Division of Hematology and Oncology is the only example where physicians in the UBMD, Kaleida/GPPC and ECMC systems belongs to the same group, without distinction between 'academia' and “private practice.” 

  • Faculty
    11/25/24
    Our faculty have distinguished themselves as innovative researchers, dedicated teachers and trusted clinicians.
  • Education & Training
    2/7/17
    Whether you’re a medical student, resident or fellow, we’re committed to furthering your interests and skills in hematology and oncology.
  • Research
    11/27/24
    We conduct a wide variety of basic, clinical and translational research. We develop and test new cancer treatments and collaborate across the full spectrum of oncology research.
  • News
    2/7/17
    Read the latest news and media coverage about our division, faculty and research.
  • Clinical Care
    7/13/20
    Along with teaching and research, our faculty are committed to providing exceptional inpatient and outpatient care to the Western New York community. Our board-certified oncologists provide the full range of diagnostic and therapeutic care at our affiliated hospitals and medical centers.
  • Calendar & Events
    2/7/17
    Learn about upcoming events in our division.
  • Contact Us
    2/7/17
    Contact us if you have questions about our division.

Contact Us

Chief, Hematology/Oncology

Pili, Roberto

Roberto Pili, MD

Associate Dean for Cancer Research and Integrative Oncology

Clinical and Translational Research Center 875 Ellicott Street, Room 6085 Buffalo, NY 14203

Phone: (716) 881-8918

Email: rpili@buffalo.edu